About ERDAFITINIB
Class: | Tyrosine Kinase Inhibitor
Use: | Treatment of locally advanced or metastatic urothelial carcinoma in adults with susceptible FGFR3 or FGFR2 genetic alterations
Adult dose: | 4 mg orally once daily; may be increased to 8 mg once daily based on tolerability and response
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Fatigue, diarrhea, dry mouth, decreased appetite, nausea, stomatitis, and increased liver enzymes
Contraindications: | H
Drug Class
Tyrosine Kinase Inhibitor
Uses & Indications
Treatment of locally advanced or metastatic urothelial carcinoma in adults with susceptible FGFR3 or FGFR2 genetic alterations
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Janssen-Cilag S.p.A., ITALY
Package Size
56's
Price & Supplier
Price in UAE: AED 239809.08
Dosage Information
Adult Dose
4 mg orally once daily; may be increased to 8 mg once daily based on tolerability and response
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Fatigue, diarrhea, dry mouth, decreased appetite, nausea, stomatitis, and increased liver enzymes
Contraindications & Precautions
Hypersensitivity to erdafitinib or any component of the formulation; severe hepatic impairment
Important Warnings
Risk of ocular toxicity (including retinal pigment epithelial detachment), hyperphosphatemia, and hepatotoxicity; monitor for signs of these conditions and manage accordingly
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.